ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 33 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $48,000 | -68.4% | 54,000 | -58.8% | 0.01% | -70.0% |
Q4 2015 | $152,000 | +32.2% | 131,000 | +4.0% | 0.03% | +7.1% |
Q3 2015 | $115,000 | +33.7% | 126,000 | +50.0% | 0.03% | +33.3% |
Q1 2015 | $86,000 | +56.4% | 84,000 | +58.5% | 0.02% | +31.2% |
Q3 2014 | $55,000 | – | 53,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |